Effect of Vestibular Rehabilitation Combined With Dual-Task Training in Patients With Unilateral Vestibular Hypofunction (VRT-DT)

November 13, 2026 updated by: Danah Mohammed Alyahya, Majmaah University

The Effect of the Vestibular Rehabilitation Combined With Dual-task Training Among Unilateral Vestibular Hypofunction Patients.

Unilateral vestibular hypofunction (UVH) is a condition in which the balance system in one inner ear does not function properly. People with this condition may experience dizziness, blurred vision during head movements, difficulty maintaining balance, and problems walking, particularly when performing two tasks at the same time.

Vestibular rehabilitation is an exercise-based treatment designed to improve balance, gaze stability, and daily functioning. Dual-task training involves performing a physical activity while simultaneously completing a mental or another physical task, such as walking while counting backward.

The purpose of this study is to investigate whether combining dual-task training with vestibular rehabilitation is more effective than traditional vestibular rehabilitation alone in improving vestibular function, dizziness, balance, and walking ability in adults with unilateral vestibular hypofunction.

This study is a single-blind randomized controlled trial involving 50 adults aged 18 to 65 years with unilateral vestibular hypofunction. Participants will be randomly assigned to one of two groups. The first group will receive traditional vestibular rehabilitation, while the second group will receive vestibular rehabilitation combined with dual-task training. Both groups will complete two treatment sessions per week for four weeks, for a total of eight sessions.

Participants will undergo assessments before and after the four-week intervention to evaluate vestibular function, dizziness-related disability, balance, walking ability, attention, and working memory. The findings may help determine whether adding dual-task training provides additional benefits for people with unilateral vestibular hypofunction.

Study Overview

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Adults aged 18 to 65 years.
  • Patients with a physician-confirmed diagnosis of unilateral vestibular -hypofunction (UVH).
  • Male and female participants.
  • Ability to walk independently and safely for at least 6 meters.
  • Ability to attend at least 80% of the scheduled treatment sessions.

Exclusion Criteria:

  • Patients diagnosed with bilateral vestibular hypofunction.
  • Presence of neurological disorders that affect balance.
  • Presence of musculoskeletal disorders that affect balance.
  • Cognitive impairment affecting task performance, defined as a Montreal -Cognitive Assessment (MoCA) score below 26.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: VR Group

Participants in this group will receive traditional vestibular rehabilitation consisting of gaze stabilization exercises (VOR x1 and VOR x2), habituation exercises, and balance training. Balance exercises will include standing on firm and foam surfaces with eyes open and closed, tandem standing, tandem walking, and walking with head movements. The intervention will be delivered twice weekly for four weeks, totaling eight treatment sessions.

Participants will receive traditional vestibular rehabilitation consisting of gaze stabilization, habituation, and balance exercises. Gaze stabilization includes VOR x1 exercises (1-2 minutes, 2-3 times) and VOR x2 exercises (1 minute, 2-3 times), performed with horizontal and vertical head movements. Habituation exercises involve repeated symptom-provoking movements, such as bending, head rotation, and turning (3-5 repetitions, 2-3 times). Balance training includes standing on firm and foam surfaces with eyes open and closed, tandem standing (30 seconds, 3-5 repetitions), tandem walking (10 steps, 3-5 repetitions), and walking 6 meters with head turns (3-5 repetitions). Participants will attend two sessions per week for four weeks, totaling eight sessions.

Experimental: VR Group With Dual-Task Training

Participants in this group will receive vestibular rehabilitation combined with dual-task training. The intervention will involve performing vestibular and balance exercises simultaneously with cognitive or motor tasks, including backward counting, reciting months in reverse order, naming animals, digit recall, serial subtraction, backward spelling, and walking while carrying a cup of water. The intervention will be delivered twice weekly for four weeks, totaling eight treatment sessions.

Participants will receive vestibular rehabilitation combined with simultaneous cognitive or motor tasks. Exercises include VOR x1 while counting backward from 100; VOR x2 while reciting months in reverse order; standing on foam while naming animals; standing on foam with eyes closed while recalling digit sequences; tandem standing while subtracting seven repeatedly from 100; tandem walking while spelling a five-letter word backward; walking with head turns while carrying a cup of water; and walking 6 meters while counting backward from 50. The intervention combines vestibular and balance activities with secondary tasks to challenge cognitive-motor performance. Participants will attend two sessions per week for four weeks, totaling eight sessions.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in Vestibulo-Ocular Reflex (VOR) Gain
Time Frame: Baseline and immediately after the 4-week intervention

Vestibulo-ocular reflex (VOR) gain will be assessed using the Video Head Impulse Test (vHIT), an objective measure of semicircular canal function. VOR gain will be measured before and after the four-week intervention to evaluate changes in vestibular function and compare the effects of traditional vestibular rehabilitation with vestibular rehabilitation combined with dual-task training.

Baseline and immediately after the 4-week intervention
Change in Vestibular Evoked Myogenic Potential (VEMP) Responses
Time Frame: Baseline and immediately after the 4-week intervention

Otolith organ function will be assessed using cervical Vestibular Evoked Myogenic Potentials (cVEMP) to evaluate saccular function and ocular Vestibular Evoked Myogenic Potentials (oVEMP) to evaluate utricular function. Assessments will be conducted before and after the four-week intervention to investigate changes in otolith function and compare responses between the two intervention groups.

Baseline and immediately after the 4-week intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

November 15, 2026

Primary Completion (Estimated)

December 30, 2026

Study Completion (Estimated)

January 30, 2027

Study Registration Dates

First Submitted

November 13, 2026

First Submitted That Met QC Criteria

November 13, 2026

First Posted (Actual)

November 19, 2026

Study Record Updates

Last Update Posted (Actual)

November 19, 2026

Last Update Submitted That Met QC Criteria

November 13, 2026

Last Verified

November 1, 2026

More Information

Terms related to this study

Other Study ID Numbers

  • IRB-097-2026

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe